Complete Solutions for today's
Wound Care
Challenges
WHO WE ARE
The Nation's Leading Integrated Wound Care Platform.
Delivering advanced biologics, diagnostics, NPWT, reimbursement solutions, and clinical support to providers nationwide.
- Nationwide Reach
- Category Leading Solutions
- Reimbursement Expertise
- End to End Support
A focus on
The Full Wound Care Continuum, Under One Roof
Wound care rarely comes down to a single product or a single step. It's a continuum — from assessment, to debridement, to advanced treatment, to closure. New Horizon brings together five modalities so clinicians can address every stage of that continuum, backed by the billing, education, and clinical support to make it all work in practice.
Advanced skin substitutes
Our biologics portfolio — including AdvoGraft One, XAM, and AmchoPlast — features amniotic and placental-derived allografts intended for use across a range of acute and chronic wounds, aligned with today’s regulatory and reimbursement requirements.
Diagnostic imaging solutions
Our exclusive U.S. partnership with Kent Imaging brings SnapshotNIR and SnapshotGLO to the point of care — providing non-contact visualization of tissue oxygenation and areas of elevated bacterial load to inform clinical decision-making.
Negative Pressure Wound Therapy
Platform Wound Dressing (PWD) replaces foam and gauze with a transparent, single-layer design that distributes negative pressure evenly across the wound surface — operating at pressures as low as –50 mmHg.
(UAW) Debridement
Our Söring UAW instruments use 25 kHz ultrasonic cavitation to remove devitalized tissue and disrupt biofilm while preserving surrounding tissue — enabling precise debridement in the OR, clinic, or bedside, often under local anesthesia.
Micro-Autografting
The Xpansion® Kit transforms a small donor sample into evenly sized micro-grafts, designed to maximize wound coverage while minimizing donor site size — with procedures that can be performed under local anesthesia, in or out of the OR.
ONE PARTNER, EVERY STAGE
Built for the Way Clinicians Actually Work
Complex wounds don’t follow a straight line. A diabetic foot ulcer may call for imaging to visualize tissue oxygenation, ultrasonic debridement to address biofilm, a skin substitute to support coverage, and negative pressure therapy to manage the wound environment. When each of those modalities comes from a different vendor, clinicians lose time and practices carry more operational burden.
New Horizon consolidates the continuum. One partner, one portfolio, one point of contact — spanning assessment, debridement, treatment, and closure.
| Assess | Debride | Treat | Close |
|---|---|---|---|
| SnapshotNIR & SnapshotGLO — Visualize tissue oxygenation and areas of elevated bacterial load at the point of care. | Söring UAW — Remove devitalized tissue and disrupt biofilm with 25 kHz ultrasonic cavitation. | PWD & skin substitutes — Apply negative pressure therapy and amniotic allografts to complex wounds. | Xpansion® Micro-Autografting — Deliver autologous coverage with minimal donor site impact. |
Beyond products, our team delivers reimbursement expertise, clinical education, and hands-on implementation support — so the full continuum integrates into your practice.
TRUSTED ACROSS THE PORTFOLIO
Five Modalities. One Standard of Quality.
From biologics to diagnostic imaging, NPWT to ultrasonic debridement to micro-autografting — every product in our portfolio is selected for clinical evidence and the needs of modern wound care practices.
- Exclusive category-leading partnerships
- Beneficial outcomes
- Reimbursement-ready solutions
Join us in
Redefining what’s possible
Whether you’re looking to optimize your operations or revolutionize your wound care protocols.
Let’s build your wound care program the way it should be built — complete.













